IL1B and inflammatory bowel disease: Ahn et al. showed that ginsenoside Rf significantly decreased the production of IL-1β, IL-6, TNF-α, NO, and ROS in IBD (Fig. 2b), indicating that ginsenoside Rf could treat IBD by inhibiting the expression of inflammatory factors [6].